363 related articles for article (PubMed ID: 28823401)
21. Verapamil hepatic clearance in four preclinical rat models: towards activity-based scaling.
Nicolaï J; De Bruyn T; Van Veldhoven PP; Keemink J; Augustijns P; Annaert P
Biopharm Drug Dispos; 2015 Oct; 36(7):462-80. PubMed ID: 25963583
[TBL] [Abstract][Full Text] [Related]
22. A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance Concept.
Sugiyama Y; Aoki Y
Drug Metab Dispos; 2023 Sep; 51(9):1067-1076. PubMed ID: 37407092
[TBL] [Abstract][Full Text] [Related]
23. Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.
Wang HJ; Benet LZ
Drug Metab Dispos; 2019 Dec; 47(12):1397-1402. PubMed ID: 31563869
[TBL] [Abstract][Full Text] [Related]
24. Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the "Albumin-Mediated" Hepatic Uptake Mechanism on the Basis of the "Facilitated-Dissociation Model".
Kim SJ; Lee KR; Miyauchi S; Sugiyama Y
Drug Metab Dispos; 2019 Feb; 47(2):94-103. PubMed ID: 30504137
[TBL] [Abstract][Full Text] [Related]
25. In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods.
Poulin P; Kenny JR; Hop CE; Haddad S
J Pharm Sci; 2012 Feb; 101(2):838-51. PubMed ID: 22009717
[TBL] [Abstract][Full Text] [Related]
26. Impact of Extensive Plasma Protein Binding on the In Situ Hepatic Uptake and Clearance of Perampanel and Fluoxetine in Sprague Dawley Rats.
Bteich M; Poulin P; Piette S; Haddad S
J Pharm Sci; 2020 Oct; 109(10):3190-3205. PubMed ID: 32649937
[TBL] [Abstract][Full Text] [Related]
27. Uridine 5'-Diphospho-glucuronosyltransferase 1A3 (UGT1A3) Prediction of Hepatic Clearance of Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Substrate Telmisartan by Glucuronidation Using In Vitro-In Vivo Extrapolation (IVIVE).
Gabor-Worwa E; Kowal-Chwast A; Gaud N; Gogola D; Littlewood P; Smoluch M; Brzózka K; Kus K
Eur J Drug Metab Pharmacokinet; 2024 May; 49(3):393-403. PubMed ID: 38642299
[TBL] [Abstract][Full Text] [Related]
28. Disease-induced alterations in plasma drug-binding proteins and their influence on drug binding percentages in dogs.
Ikenoue N; Saitsu Y; Shimoda M; Kokue E
Vet Q; 2000 Jan; 22(1):43-9. PubMed ID: 10682387
[TBL] [Abstract][Full Text] [Related]
29. Consideration of albumin-mediated hepatic uptake for highly protein-bound anionic drugs: Bridging the gap of hepatic uptake clearance between in vitro and in vivo.
Miyauchi S; Kim SJ; Lee W; Sugiyama Y
Pharmacol Ther; 2022 Jan; 229():107938. PubMed ID: 34171335
[TBL] [Abstract][Full Text] [Related]
30. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
Poulin P; Burczynski FJ; Haddad S
J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
[TBL] [Abstract][Full Text] [Related]
31. Comparative assessment of In Vitro-In Vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs.
Poulin P; Hop CE; Ho Q; Halladay JS; Haddad S; Kenny JR
J Pharm Sci; 2012 Nov; 101(11):4308-26. PubMed ID: 22890957
[TBL] [Abstract][Full Text] [Related]
32. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
Kosugi Y; Hosea N
Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism.
Fukuchi Y; Toshimoto K; Mori T; Kakimoto K; Tobe Y; Sawada T; Asaumi R; Iwata T; Hashimoto Y; Nunoya KI; Imawaka H; Miyauchi S; Sugiyam Y
J Pharm Sci; 2017 Sep; 106(9):2704-2714. PubMed ID: 28465151
[TBL] [Abstract][Full Text] [Related]
34. Using the Dynamic Well-Stirred Model to Extrapolate Hepatic Clearance of Organic Anion-Transporting Polypeptide Transporter Substrates without Assuming Albumin-Mediated Hepatic Drug Uptake.
Yan Z; Ma L; Hwang N; Huang J; Kenny JR; Hop CECA
Drug Metab Dispos; 2024 May; 52(6):548-554. PubMed ID: 38604729
[TBL] [Abstract][Full Text] [Related]
35. Unbound liver concentration is the true inhibitor concentration that determines cytochrome P450-mediated drug-drug interactions in rat liver.
Iwasaki S; Hirabayashi H; Funami M; Amano N
Xenobiotica; 2017 Jun; 47(6):488-497. PubMed ID: 27435455
[TBL] [Abstract][Full Text] [Related]
36. Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance.
Matsunaga N; Ufuk A; Morse BL; Bedwell DW; Bao J; Mohutsky MA; Hillgren KM; Hall SD; Houston JB; Galetin A
Drug Metab Dispos; 2019 Mar; 47(3):215-226. PubMed ID: 30593544
[TBL] [Abstract][Full Text] [Related]
37. Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred model.
Wan H; Bold P; Larsson LO; Ulander J; Peters S; Löfberg B; Ungell AL; Någård M; Llinàs A
Curr Drug Metab; 2010 Sep; 11(7):583-94. PubMed ID: 20629632
[TBL] [Abstract][Full Text] [Related]
38. In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes.
Carlile DJ; Stevens AJ; Ashforth EI; Waghela D; Houston JB
Drug Metab Dispos; 1998 Mar; 26(3):216-21. PubMed ID: 9492383
[TBL] [Abstract][Full Text] [Related]
39. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
Nishimuta H; Watanabe T; Bando K
AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs.
Hallifax D; Houston JB
J Pharm Sci; 2012 Aug; 101(8):2645-52. PubMed ID: 22700322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
